Didier Frappaz
- Genetics top 0.05%
- Glioma Diagnosis and Treatment 120
- Neurology top 0.2%
- Neuroblastoma Research and Treatments 76
- Cancer Research top 1%
-
- Brain Metastases and Treatment 44
- Epidemiology top 2%
- Meningioma and schwannoma management 29
-
- Childhood Cancer Survivors' Quality of Life 26
-
- Cancer therapeutics and mechanisms 19
-
- Testicular diseases and treatments 18
-
- Ocular Oncology and Treatments 16
- Co-authors
- Roger StuppRoger HenrikssonFrançois DozThierry PhilipChristine MarosiAnnika MalmströmHenrik SchultzBjørn Henning Grønberg
- Cited by
- GeneticsNeurologyCancer Research
- Partner nations
- FranceUnited KingdomItaly
In The Last Decade
Didier Frappaz
266 papers receiving 8.0k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Genetics 4.6k
- Neurology 2.7k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 2.1k
- Epidemiology 1.4k
Countries citing papers authored by Didier Frappaz
This map shows the geographic impact of Didier Frappaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Frappaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Frappaz more than expected).
Fields of papers citing papers by Didier Frappaz
This network shows the impact of papers produced by Didier Frappaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Frappaz. The network helps show where Didier Frappaz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Didier Frappaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2022 | 4 | |
| 3 | 2021 | 21 | |
| 4 | 2019 | 5 | |
| 5 | 2018 | 9 | |
| 6 | 2016 | 9 | |
| 7 | 2013 | 13 | |
| 8 | 2011 | 5 | |
| 9 | 2011 | 25 | |
| 10 | 2010 | 15 | |
| 11 | 2010 | 36 | |
| 12 | Histopathological grading of intracranial pediatric ependymomas | 2008 | 3 |
| 13 | Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas? | 2004 | 7 |
| 14 | 2003 | 32 | |
| 15 | Temozolomide in malignant gliomas of childhood | 2002 | 2 |
| 16 | 2002 | 6 | |
| 17 | 1998 | 4 | |
| 18 | 1996 | 9 | |
| 19 | Avant-propos : Cancers de l'enfant | 1993 | 4 |
| 20 | [Seriousness of severe acquired aplastic anemia in children. Apropos of 32 cases]. | 1986 | 1 |
About Didier Frappaz
Didier Frappaz is a scholar working on Genetics, Neurology and Hematology, having authored 274 papers that have together received 8.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (120 papers), Neuroblastoma Research and Treatments (76 papers), Brain Metastases and Treatment (44 papers), Meningioma and schwannoma management (29 papers), Childhood Cancer Survivors' Quality of Life (26 papers), Cancer therapeutics and mechanisms (19 papers), Testicular diseases and treatments (18 papers) and Ocular Oncology and Treatments (16 papers). The work is most often cited by research in Genetics (4.6k citations), Neurology (2.7k citations) and Cancer Research (1.1k citations). Didier Frappaz has collaborated with scholars based in France, United Kingdom and Italy. Frequent co-authors include Roger Stupp, Roger Henriksson, François Doz, Thierry Philip, Christine Marosi, Annika Malmström, Henrik Schultz, Bjørn Henning Grønberg, Benoît Lhermitte and Johan Rosell. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.